Jerusalem, Israel

Naomi Bluma Zak

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignees: Biomx Ltd., Keio University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naomi Bluma Zak. Retrieved from https://idiyas.com/inventor/naomi-bluma-zak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naomi Bluma Zak: Innovator in Bacteriophage Therapy

Introduction

Naomi Bluma Zak is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of medical science, particularly in the area of bacteriophage therapy. Her innovative work focuses on developing therapeutic solutions for inflammatory bowel disease.

Latest Patents

Naomi Bluma Zak holds 1 patent for her invention titled "Bacteriophage for modulating inflammatory bowel disease." This patent discloses bacteriophage compositions and their therapeutic uses. The invention relates to bacteriophage capable of lysing bacterial strains associated with inflammatory bowel disease, thereby modulating the disease effectively.

Career Highlights

Throughout her career, Naomi has worked with esteemed institutions, including Keio University and Biomx Ltd. Her research has been pivotal in advancing the understanding and treatment of inflammatory bowel disease through innovative bacteriophage applications.

Collaborations

Naomi has collaborated with notable professionals in her field, including Kenya Honda and Koji Atarashi. These partnerships have further enriched her research and contributed to the development of her groundbreaking inventions.

Conclusion

Naomi Bluma Zak's work in bacteriophage therapy represents a significant advancement in the treatment of inflammatory bowel disease. Her innovative approach and dedication to research continue to inspire future developments in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…